Cristiano Ferrario, Yusuf Menda, Shadi Abdar Esfahani, Bhumsuk Keam, Andrew Thompson, Jennifer Friedmann, Kellie Bodeker, Catherine Belle Meador, Heather Burks, Darlene Lu, Kai-Uwe Klein, Elena Herranz Muelas, Nicolas Salem, Tanja Fude-Blumer, Joanne Randolph, Raghav Chawla. "Phase I study of [
                    <sup>225</sup>
                    Ac]Ac-ETN029, a DLL3-targeted radioligand therapy, in patients with advanced DLL3-expressing solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3174